Lung Function in Infants with Cystic Fibrosis Diagnosed by Newborn Screening
- 15 December 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 178 (12) , 1238-1244
Abstract
Rationale: Progressive lung damage in cystic fibrosis (CF) starts in infancy, and early detection may aid preventative strategies. Objectives: To measure lung function in infants with CF diagnosed by newborn screening and describe its association with pulmonary infection and inflammation. Methods: Infants with CF (n = 68, 6 weeks to 30 months of age) and healthy infants without CF (n = 49) were studied. Forced vital capacity, FEV0.5, and forced expiratory flows at 75% of exhaled vital capacity (FEF75) were measured using the raised-volume rapid thoracoabdominal compression technique. Forty-eight hours later, infants with CF had bronchoalveolar lavage (BAL) for assessment of pulmonary infection and inflammation. Measurements and Main Results: In the CF group, the deficit in FEV0.5 z score increased by −0.77 (95% confidence interval, −1.14 to −0.41; P < 0.001) with each year of age. The mean FEV0.5 z score did not differ between infants with CF and healthy control subjects less than 6 months of age (−0.06 and 0.02, respectively; P = 0.87). However, the mean FEV0.5 z score was lower by 1.15 in infants with CF who were older than 6 months of age compared with healthy infants (P < 0.001). FVC and FEF75 followed a similar pattern. Pulmonary infection and inflammation in BAL samples did not explain the lung function results. Conclusions: Lung function, measured by forced expiration, is normal in infants with CF at the time of diagnosis by newborn screening but is diminished in older infants. These findings suggest that in CF the optimal timing of therapeutic interventions aimed at preserving lung function may be within the first 6 months of life.Keywords
Funding Information
- National Health and Medical Research Council (3211912)
- National Health and Medical Research Council (#458513)
- Cystic Fibrosis Foundation (SLY04A0)
- Murdoch Children’s Research Institute
This publication has 36 references indexed in Scilit:
- Airway remodelling in children with cystic fibrosisThorax, 2007
- Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort studyThe Lancet, 2007
- Endpoints for Clinical Trials in Young Children with Cystic FibrosisProceedings of the American Thoracic Society, 2007
- Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume testsThorax, 2007
- Exhaled nitric oxide is not reduced in infants with cystic fibrosisEuropean Respiratory Journal, 2006
- Lower Airway Inflammation in Infants with Cystic Fibrosis Detected by Newborn ScreeningPediatric Pulmonology, 2005
- Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in EuropeThe Journal of Pediatrics, 2005
- Diagnosis of cystic fibrosis after newborn screening: The Australasian experience?twenty years and five million babies later: A consensus statement from the Australasian paediatric respiratory groupPediatric Pulmonology, 2005
- Airway function at one year: association with premorbid airway function, wheezing, and maternal smokingThorax, 2001
- Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory SocietyEuropean Respiratory Journal, 2000